[A two-site combined prediction model based on HOXA9 DNA methylation for early screening of risks of meningioma progression].
High HOXA9 methylation level is a predictor for poor prognosis of meningiomas, and the combined prediction model based on its CpG sites provides a new approach to early screening of meningioma patients at risk of progression.
Authors
- Zhen Li (ORCID: https://orcid.org/0000-0002-6364-6226)
- Rui Zhen Tan (ORCID: https://orcid.org/0000-0002-7464-5245)
- Liang Han (ORCID: https://orcid.org/0000-0001-8674-6433)
- Na Tian (ORCID: https://orcid.org/0000-0001-7800-6072)
- Xiuliang Bao (ORCID: https://orcid.org/0000-0002-2042-7090)
Institutions
- Zhejiang Chinese Medical University (CN)
- Union Hospital (HK)
- Jilin University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2024-11-20
- DOI
- https://doi.org/10.12122/j.issn.1673-4254.2024.11.07
- Primary Topic
- Meningioma and schwannoma management
- Type
- article